Friday , May 27 2022

Anti-breast cancer drugs. 2x Survival Rate – Fresh


Breast cancer is the most common type of cancer among Thai women and women worldwide. At present, the number of people with this disease is increasing each year. Often, early stages of breast cancer do not show signs or symptoms. The patient is aware that the cancer spreads to the third to fourth. Breast Cancer Treatment Previously, surgery, chemotherapy, anti-hormonal treatment, but in the last year there is another treatment. After the United States Pfizer. The pioneering drug for breast cancer in the spread and spread. In Thailand, this drug has been approved by the drug. During the last year, Pfizer Thailand gave this drug to the Thai Oncology Society last year. For treating 50 patients with metastatic breast cancer, Assoc. Professor Dr. Sriroonpong Men, Head of Cancer Medical Center of Excellence King Chulalongkorn Memorial Hospital was completed President of the Thai Oncology Association said that the drug is an anti-cancer drug that prevents the operation of CDK 4/6, approved by the Ministry of Food and Drugs as the first drug. The first line in patients with advanced or metastatic breast cancer. ER + / HER 2-menopause. Dr Men said that the drug had two different formulas used differently. The first formulation is used by patients who have never received any hormonal treatment. […]

The breast cancer breastfeeding drugs. The survival rate has increased 2 times first on nations.

Source link